Skip to main content

This instrument will make it possible to build (almost) any other

The Precision Instrumentation Technologies facility has been outfitted with a CNC milling machine, a high-performance instrument that will help Rockefeller engineers custom-make scientific devices.

>

New approach to cancer immunotherapy overcomes toxicity hurdle

Using a unique mouse model, Rockefeller scientists have developed a new strategy in cancer immunotherapy that is more safe and effective than other treatments of its kind.

To see what’s right in front of you, your brain may need some rewiring

As you encounter new experiences and form new memories, your brain changes. Now, researchers show that some of these change occur in a brain region devoted to visual perception.

Herbert Gibbs, who brightened Rockefeller’s campus for 45 years, dies at age 74

A janitor and porter, “Mister Gibbs” was known for his infectious smile and his dedication to the university community.

Rockefeller welcomes new librarian, Matthew V. Covey

Covey is bringing an inside-out approach to the library’s work, with librarians visiting scientists in their labs to help with everything from training sessions to data management.

In tiny worms, researchers find spiking neurons—and clues about brain computation

Studying neurons in C. elegans, researchers made a surprising discovery: these roundworms, like most animals, process information using a digital, electric code.

C. David Allis accepts Lasker Award for insights into gene regulation

During the time-honored Lasker Award ceremony, Allis outlined the five-decade-long history of research on histones and their modification.

Scientists investigate how DEET confuses countless critters

DEET, a chemical in bug sprays, affects the behavior of highly diverse organisms—but how it works remains unclear. New research in C. elegans shows that the compound exploits unique receptors and neurons to interfere with the animals’ response to odors.

In clinical trials, new antibody therapy controls HIV for months after treatment

A new clinical trial shows that broadly neutralizing antibodies can suppress HIV for up to four months, far longer than currently available drugs.

Study of protein “trafficker” provides insight into autism and other brain disorders

Researchers have discovered that the protein ASTN2 shuttles receptors away from the surface of neurons, a process that facilitates efficient brain activity.